VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q1 2025

Top Holdings9 positions

Checking export access…
Activity:
AGGAGG
ETF

ISHARES TR

3.7M$366M41.7%$91.62+2.08%
20 qtrssince 2020-Q2
Increased
72
TLTTLT
ETF

ISHARES TR

2.1M$191.3M21.8%$91.28-6.39%
12 qtrssince 2022-Q2
Unchanged
0
SPHYSPHY
ETF

STATE STREET SPDR PORTFOLIO HIGH YIELD BOND ETF

7.3M$171.1M19.5%$20.880.00%
1 qtr
New
97
IVVIVV
ETF

iShares Trust CORE S&P500 ETF

166,970$93.8M10.7%$433.46+27.33%
20 qtrssince 2020-Q2
Unchanged
0
VCSHVCSH
ETF

VANGUARD SHORT-TERM CORPORATE BOND ETF

277,700$21.9M2.5%$72.57+2.18%
4 qtrssince 2024-Q2
Increased
82
133,300$10.4M1.2%——
4 qtrssince 2024-Q2
Increased
74
IGSBIGSB
ETF

ISHARES 1-5 YEAR INVESTMENT GRADE CORPORATE BOND ETF

187,500$9.8M1.1%$48.35+5.96%
4 qtrssince 2024-Q2
Increased
73
VTVVTV
ETF

VANGUARD INDEX FDS

55,020$9.5M1.1%$148.23+13.00%
12 qtrssince 2022-Q2
Unchanged
0
VUGVUG
ETF

Vanguard Index Funds MORNINGSTAR GROWTH ETF

8,500$3.2M0.4%$34.90+75.93%
11 qtrssince 2022-Q3
Unchanged
0
$877.1M
AUM
9
Positions
Q1 2025
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+22%Q4'23$749.8M-19%Q1'24$604.4M+20%Q2'24$726.7M+7%Q3'24$779.1M-20%Q4'24$624.1M+41%Q1'25$877.1M
Activity profile
$ moved · Q1'25
New69%Increased31%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.1 years
<1Q11%1-4Q0%1-2Y0%2Y+89%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $877.1M across 9 positions as of Q1 2025. Top holdings: AGG (41.7%), TLT (21.8%), SPHY (19.5%). Fund DNA: Steady Compounder. HoldingsIntel Score: 1/5.0.

Q1 2025 Summary

Added 1 new position, increased 4. Top move: SPHY (NEW, conviction 97). Portfolio: $877M across 9 positions.

Top holdings by portfolio weight

Total AUM$877M
AGG41.73%
TLT21.81%
SPHY19.51%
IVV10.70%
VCSH2.50%
VANGUARD SHO1.19%
IGSB1.12%
VTV1.08%
VUG0.36%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L84
Conviction49
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVANGUARD INDEX FDS
Q3 2025 → Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAMERICAN CENTY ETF TR
Q4 2025 → Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVANGUARD INTL EQUITY INDEX F
Q1 2026 → Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used